CXCL13 and neoplasm: The PRF1 cluster also upregulated Th1 markers IFNG and CXCL13, which contribute to tumor control by up-regulating HLA-II and promoting the formation of tertiary lymphoid structures (TLS), respectively51,52 (Fig. 5E).